HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kavita Y Sarin Selected Research

Basal Cell Neoplasms (Basal Cell Cancer)

1/2018Genomic Stability in Syndromic Basal Cell Carcinoma.
1/2018Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kavita Y Sarin Research Topics

Disease

16Neoplasms (Cancer)
01/2021 - 08/2005
10Basal Cell Carcinoma (Rodent Ulcer)
07/2021 - 03/2015
4Melanoma (Melanoma, Malignant)
01/2019 - 01/2016
3Dermatomyositis (Dermatopolymyositis)
04/2021 - 02/2014
3Nevus (Nevi)
01/2019 - 09/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2019
2Basal Cell Neoplasms (Basal Cell Cancer)
01/2018 - 01/2018
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
01/2022
1Blister (Bulla)
01/2022
1Neurofibroma
01/2021
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2021
1Drug-Related Side Effects and Adverse Reactions
06/2019
1Hypohidrosis
06/2019
1Glioma (Gliomas)
01/2018
1Leukemia
01/2018
1Hidradenitis
01/2018
1Disease Progression
01/2018
1Basosquamous Carcinoma
01/2017
1Inflammation (Inflammations)
01/2017
1Wells syndrome
09/2012

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2017
5Pharmaceutical PreparationsIBA
01/2018 - 03/2015
4RNA (Ribonucleic Acid)IBA
01/2022 - 06/2017
4HhAntag691IBA
01/2018 - 03/2015
3Proteins (Proteins, Gene)FDA Link
01/2018 - 08/2005
2remetinostatIBA
01/2022 - 01/2021
2Transcription Factors (Transcription Factor)IBA
01/2018 - 11/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2017
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2017 - 08/2005
1Histone Deacetylase InhibitorsIBA
01/2022
1Toll-Like Receptor 7IBA
04/2021
1bazlitoranIBA
04/2021
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
10/2020
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019
1IntegrinsIBA
11/2018
1Fibronectins (Fibronectin)IBA
11/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2018
1AsbestosIBA
10/2018
1Azathioprine (Imuran)FDA LinkGeneric
01/2018
1ZincIBA
01/2018
1ForminsIBA
01/2018
1Atorvastatin (Lipitor)FDA Link
01/2018
1Histone Deacetylase 1IBA
11/2017
1Staphylococcal Protein A (Protein A)IBA
06/2017
1Vitamin DFDA LinkGeneric
01/2017
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2017
1Actins (F Actin)IBA
01/2017
1sonidegibIBA
03/2016
1Adrenergic alpha-Agonists (Adrenergic alpha-Agonist)IBA
01/2016
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2016
1Capecitabine (Xeloda)FDA Link
02/2014
1Adalimumab (Humira)FDA Link
09/2012

Therapy/Procedure

9Therapeutics
01/2022 - 03/2015
2Drug Therapy (Chemotherapy)
06/2019 - 09/2013